William Plovanic
Stock Analyst at Canaccord Genuity
(3.66)
# 2,166
Out of 4,639 analysts
659
Total ratings
46.1%
Success rate
3.6%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBLL CeriBell | Reiterated: Buy | $25 → $26 | $19.30 | +34.72% | 15 | Aug 11, 2026 | |
| PLSE Pulse Biosciences | Maintained: Buy | $32 → $43 | $41.51 | +3.59% | 3 | Aug 10, 2026 | |
| AORT Artivion | Reiterated: Buy | $36 → $39 | $26.31 | +48.23% | 13 | Aug 7, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Buy | $35 → $40 | $22.81 | +75.36% | 14 | Aug 7, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | $152 → $196 | $124.78 | +57.08% | 35 | Aug 7, 2026 | |
| TLSI TriSalus Life Sciences | Maintained: Buy | $7 | $5.58 | +25.45% | 20 | Aug 7, 2026 | |
| CVRX CVRx, Inc. | Maintained: Buy | $10 → $5 | $2.37 | +110.97% | 38 | Aug 7, 2026 | |
| PODD Insulet | Maintained: Buy | $249 → $179 | $142.85 | +25.31% | 44 | Aug 6, 2026 | |
| ATEC Alphatec Holdings | Reiterated: Buy | $25 → $19 | $9.49 | +100.21% | 9 | Aug 5, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $124 → $95 | $88.41 | +7.45% | 56 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $374 | $325.98 | +14.73% | 31 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $90 | $87.65 | +2.68% | 45 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 | $92.03 | -7.64% | 40 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $66 | $50.46 | +30.80% | 43 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $41.64 | +32.08% | 37 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $29.35 | +26.06% | 13 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $2.17 | +38.25% | 30 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $79 | $86.15 | n/a | 20 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $25 | $18.84 | n/a | 3 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $19 | $15.75 | n/a | 10 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $48.22 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $295 → $300 | $345.81 | n/a | 22 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $150 → $131 | $97.78 | n/a | 14 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.66 → $7 | $13.96 | n/a | 2 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 | $30.08 | n/a | 6 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $24.24 | n/a | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 → $43 | $25.12 | n/a | 17 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $86 → $70 | $89.75 | n/a | 17 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $2.28 | n/a | 10 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.31 | n/a | 7 | Feb 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.27 | n/a | 11 | Jan 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $7.71 | n/a | 6 | Nov 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $22 | - | n/a | 7 | Jul 29, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0005 | n/a | 6 | Feb 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $63 | $76.48 | n/a | 7 | Jun 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $9.65 | n/a | 4 | Jul 31, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $10.26 | n/a | 1 | Sep 9, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.07 | n/a | 1 | Jun 28, 2011 |
CeriBell
Aug 11, 2026
Reiterated: Buy
Price Target: $25 → $26
Current: $19.30
Upside: +34.72%
Pulse Biosciences
Aug 10, 2026
Maintained: Buy
Price Target: $32 → $43
Current: $41.51
Upside: +3.59%
Artivion
Aug 7, 2026
Reiterated: Buy
Price Target: $36 → $39
Current: $26.31
Upside: +48.23%
Tandem Diabetes Care
Aug 7, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $22.81
Upside: +75.36%
iRhythm Holdings
Aug 7, 2026
Maintained: Buy
Price Target: $152 → $196
Current: $124.78
Upside: +57.08%
TriSalus Life Sciences
Aug 7, 2026
Maintained: Buy
Price Target: $7
Current: $5.58
Upside: +25.45%
CVRx, Inc.
Aug 7, 2026
Maintained: Buy
Price Target: $10 → $5
Current: $2.37
Upside: +110.97%
Insulet
Aug 6, 2026
Maintained: Buy
Price Target: $249 → $179
Current: $142.85
Upside: +25.31%
Alphatec Holdings
Aug 5, 2026
Reiterated: Buy
Price Target: $25 → $19
Current: $9.49
Upside: +100.21%
TransMedics Group
Aug 5, 2026
Maintained: Buy
Price Target: $124 → $95
Current: $88.41
Upside: +7.45%
Aug 4, 2026
Maintained: Hold
Price Target: $374
Current: $325.98
Upside: +14.73%
Aug 3, 2026
Reiterated: Buy
Price Target: $82 → $90
Current: $87.65
Upside: +2.68%
Aug 3, 2026
Maintained: Hold
Price Target: $85
Current: $92.03
Upside: -7.64%
Jul 30, 2026
Reiterated: Buy
Price Target: $70 → $66
Current: $50.46
Upside: +30.80%
Jul 23, 2026
Maintained: Buy
Price Target: $55
Current: $41.64
Upside: +32.08%
Jun 29, 2026
Maintained: Buy
Price Target: $37
Current: $29.35
Upside: +26.06%
Apr 6, 2026
Maintained: Buy
Price Target: $3
Current: $2.17
Upside: +38.25%
Jan 22, 2024
Maintained: Buy
Price Target: $71 → $79
Current: $86.15
Upside: n/a
Jan 22, 2024
Maintained: Buy
Price Target: $24 → $25
Current: $18.84
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $17 → $19
Current: $15.75
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $15
Current: $48.22
Upside: n/a
Dec 15, 2023
Maintained: Hold
Price Target: $295 → $300
Current: $345.81
Upside: n/a
Dec 15, 2023
Maintained: Hold
Price Target: $150 → $131
Current: $97.78
Upside: n/a
Dec 7, 2023
Upgraded: Buy
Price Target: $3.66 → $7
Current: $13.96
Upside: n/a
Nov 30, 2023
Maintained: Hold
Price Target: $32
Current: $30.08
Upside: n/a
Nov 7, 2023
Maintained: Buy
Price Target: $65
Current: $24.24
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: $48 → $43
Current: $25.12
Upside: n/a
Aug 28, 2023
Maintained: Hold
Price Target: $86 → $70
Current: $89.75
Upside: n/a
Feb 23, 2023
Maintained: Buy
Price Target: $16 → $20
Current: $2.28
Upside: n/a
Feb 2, 2016
Maintained: Buy
Price Target: $8
Current: $1.31
Upside: n/a
Jan 11, 2016
Reiterated: Buy
Price Target: $12
Current: $4.27
Upside: n/a
Nov 5, 2015
Maintained: Buy
Price Target: $16
Current: $7.71
Upside: n/a
Jul 29, 2015
Reiterated: Hold
Price Target: $25 → $22
Current: -
Upside: n/a
Feb 2, 2015
Reiterated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Jun 5, 2014
Maintained: Buy
Price Target: $73 → $63
Current: $76.48
Upside: n/a
Jul 31, 2013
Reiterated: Hold
Price Target: $17 → $14
Current: $9.65
Upside: n/a
Sep 9, 2011
Maintained: Buy
Price Target: $45
Current: $10.26
Upside: n/a
Jun 28, 2011
Reiterated: Buy
Price Target: n/a
Current: $17.07
Upside: n/a